Compare EDU & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDU | CRL |
|---|---|---|
| Founded | 1993 | 1947 |
| Country | China | United States |
| Employees | 84111 | N/A |
| Industry | Other Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 8.6B |
| IPO Year | N/A | 1999 |
| Metric | EDU | CRL |
|---|---|---|
| Price | $50.88 | $150.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $62.80 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 718.2K | 702.0K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $12.83 | N/A |
| Revenue Next Year | $11.16 | $3.04 |
| P/E Ratio | $24.75 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $41.62 | $132.58 |
| 52 Week High | $64.97 | $228.88 |
| Indicator | EDU | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 37.72 | 33.53 |
| Support Level | $50.47 | $147.22 |
| Resistance Level | $54.97 | $184.75 |
| Average True Range (ATR) | 1.29 | 8.19 |
| MACD | -0.26 | -2.48 |
| Stochastic Oscillator | 11.14 | 1.58 |
New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.